Redeye considers Polygiene’s Q3 figures to be mixed, with higher-than-expected revenues and gross margin, while opex also exceeded our forecast, overall colored by the challenging market conditions. Most notably, the company sees signs of recovery, confirming our expectations of a recovery in Q4.
LÄS MER
